Opus Genetics, Inc. (IRD) Reports Q3 Loss, Beats Revenue Estimates

Opus Genetics, Inc. (IRD) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of$ 0.14. This compares to a loss of $0.29 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +14.29%. A quarter ago, it was expected that this company would post a loss of$ 0.25 per share when it actually produced a loss of $0.12, delivering a surprise of +52%.Over the last four quarters, the company has surp ...